In addition, a reduction of ECRG2/SPINK7 was also found in several other human malignancies, i.e., head and neck squamous cell cancer, cervical squamous cell carcinoma, and endocervical adenocarcinoma, which was associated with reduced disease-free survival in patients [4]. Here, SPINK7 is linked to endocervical adenocarcinoma.